☰

Albert Ching-Wei Koong, MD, PhD - Publications

Affiliations: 
1988-2017 Stanford University, Palo Alto, CA 
 2017- Radiation Oncology The University of Texas MD Anderson Cancer Center 
Area:
Radiation Oncology; Endoplasmic reticulum (ER) stress: Gastrointestinal cancers; Tumor microenvironment
Website:
https://faculty.mdanderson.org/profiles/albert_koong.html
Tree Info Similar researchers PubMed Report error

251 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Beach C, MacLean D, Majorova D, Melemenidis S, Nambiar DK, Kim RK, Valbuena GN, Guglietta S, Krieg C, Darvish-Damavandi M, Suwa T, Easton A, Hillson LV, McCulloch AK, McMahon RK, ... ... Koong AC, et al. Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1. The Journal of Clinical Investigation. PMID 37824211 DOI: 10.1172/JCI168277  0.467
2022 Miao YR, Thakkar K, Cenik C, Jiang D, Mizuno K, Jia C, Li CG, Zhao H, Diep A, Xu Y, Zhang XE, Yang TTC, Liedtke M, Abidi P, Leung WS, ... Koong AC, et al. Developing high-affinity decoy receptors to treat multiple myeloma and diffuse large B cell lymphoma. The Journal of Experimental Medicine. 219. PMID 35881112 DOI: 10.1084/jem.20220214  0.417
2020 Noticewala SS, Koong AC, Bloom ES, Choi S, Chronowski G, Ghafar RA, Guadagnolo BA, Gunn GB, Klopp A, Lee P, Li J, Liao Z, Ludmir EB, McAleer MF, Nguyen QN, et al. Radiation Oncology Strategies to Flatten the Curve During the Coronavirus Disease 2019 (COVID-19) Pandemic: Experience From a Large Tertiary Cancer Center. Advances in Radiation Oncology. 5: 567-572. PMID 32775771 DOI: 10.1016/J.Adro.2020.04.038  0.303
2020 Toesca DAS, Ahmed F, Kashyap M, Richelcyn M Baclay J, von Eyben R, Pollom EL, Koong AC, Chang DT. Intensified Systemic Therapy and Stereotactic Ablative Radiotherapy Dose for Patients with Unresectable Pancreatic Adenocarcinoma. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 32763253 DOI: 10.1016/J.Radonc.2020.07.053  0.31
2020 Moningi S, Ajani JA, Badgwell BD, Murphy MB, Ikoma N, Mansfield PF, Ho JC, Suh Y, Crane C, Herman JM, Holliday EB, Koay E, Koong AC, Krishnan S, Minsky B, et al. IMRT Reduces Acute Toxicity in Patients Treated With Preoperative Chemoradiation for Gastric Cancer. Advances in Radiation Oncology. 5: 369-376. PMID 32529130 DOI: 10.1016/J.Ijrobp.2019.06.2046  0.338
2020 Ibragimov B, Toesca DAS, Chang DT, Yuan Y, Koong AC, Xing L, Vogelius IR. Deep learning for identification of critical regions associated with toxicities after liver stereotactic body radiation therapy. Medical Physics. PMID 32406531 DOI: 10.1002/Mp.14235  0.32
2020 Avila S, Chang GJ, Dasari NA, Smani DA, Das P, Herman JM, Koay E, Koong A, Krishnan S, Minsky BD, Smith GL, Taniguchi C, Taggart MW, Kaur H, Holliday EB. Pathologic Response and Postoperative Complications After Short-course Radiation Therapy and Chemotherapy for Patients With Rectal Adenocarcinoma. Clinical Colorectal Cancer. PMID 32173279 DOI: 10.1016/J.Clcc.2020.02.005  0.319
2020 Lin SH, Hobbs BP, Verma V, Tidwell RS, Smith GL, Lei X, Corsini EM, Mok I, Wei X, Yao L, Wang X, Komaki RU, Chang JY, Chun SG, Jeter MD, ... ... Koong AC, et al. Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1902503. PMID 32160096 DOI: 10.1200/Jco.19.02503  0.327
2020 Koong AJ, Toesca DAS, Baclay JRM, Pollom EL, von Eyben R, Koong AC, Chang DT. The Utility of Stereotactic Body Radiotherapy for Palliation of Metastatic Pancreatic Adenocarcinoma. Practical Radiation Oncology. PMID 32119922 DOI: 10.1016/J.Prro.2020.02.010  0.387
2020 Aguilera TA, Elghonaimy E, Shehade H, Rafat M, Castellini L, Jiang D, Kariolis M, Koong A, Le QT, Ellies LG, Rankin EB, Graves EE, Giaccia AJ. Induced tumor heterogeneity reveals factors informing radiation and immunotherapy combinations. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32098769 DOI: 10.1158/1078-0432.Ccr-19-4220  0.532
2020 Ibragimov B, Toesca DA, Chang DT, Yuan Y, Koong AC, Xing L. Automated hepatobiliary toxicity prediction after liver stereotactic body radiation therapy with deep learning-based portal vein segmentation Neurocomputing. 392: 181-188. DOI: 10.1016/J.Neucom.2018.11.112  0.304
2019 Nambiar DK, Aguilera T, Cao H, Kwok S, Kong C, Bloomstein J, Wang Z, Rangan VS, Jiang D, von Eyben R, Liang R, Agarwal S, Colevas AD, Korman A, Allen CT, ... ... Koong AC, et al. Galectin-1-driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance. The Journal of Clinical Investigation. PMID 31710313 DOI: 10.1172/Jci129025  0.545
2019 Moningi S, Ludmir EB, Polamraju P, Williamson T, Melkun MM, Herman JD, Krishnan S, Koay EJ, Koong AC, Minsky BD, Smith GL, Taniguchi C, Das P, Holliday EB. Definitive hyperfractionated, accelerated proton reirradiation for patients with pelvic malignancies. Clinical and Translational Radiation Oncology. 19: 59-65. PMID 31517071 DOI: 10.1016/J.Ctro.2019.08.004  0.318
2019 Palta M, Godfrey D, Goodman KA, Hoffe S, Dawson LA, Dessert D, Hall WA, Herman JM, Khorana AA, Merchant N, Parekh A, Patton C, Pepek JM, Salama JK, Tuli R, ... Koong AC, et al. Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. Practical Radiation Oncology. 9: 322-332. PMID 31474330 DOI: 10.1016/J.Prro.2019.06.016  0.335
2019 Choi GW, Suh Y, Das P, Herman J, Holliday E, Koay E, Koong AC, Krishnan S, Minsky BD, Smith GL, Taniguchi CM, Beddar S. Assessment of setup uncertainty in hypofractionated liver radiation therapy with a breath-hold technique using automatic image registration-based image guidance. Radiation Oncology (London, England). 14: 154. PMID 31470860 DOI: 10.1186/S13014-019-1361-6  0.305
2019 Yu M, Nguyen ND, Huang Y, Lin D, Fujimoto TN, Molkentine JM, Deorukhkar A, Kang Y, San Lucas FA, Fernandes CJ, Koay EJ, Gupta S, Ying H, Koong AC, Herman JM, et al. Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer. Jci Insight. 5. PMID 31335325 DOI: 10.1172/Jci.Insight.126915  0.317
2019 Toesca DAS, Jeffrey RB, von Eyben R, Pollom EL, Poullos PD, Poultsides GA, Fisher GA, Visser BC, Koong AC, Chang DT. Predicting Pancreatic Cancer Resectability and Outcomes Based on an Objective Quantitative Scoring System. Pancreas. 48: 622-628. PMID 31091207 DOI: 10.1097/Mpa.0000000000001314  0.343
2019 Deng W, Xu C, Liu A, van Rossum PSN, Deng W, Liao Z, Koong AC, Mohan R, Lin SH. The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 133: 9-15. PMID 30935587 DOI: 10.1016/J.Radonc.2018.12.002  0.365
2019 Ibragimov B, Toesca D, Yuan Y, Koong A, Daniel C, Xing L. Neural networks for deep radiotherapy dose analysis and prediction of liver SBRT outcomes. Ieee Journal of Biomedical and Health Informatics. PMID 30869633 DOI: 10.1109/Jbhi.2019.2904078  0.304
2019 Moningi S, Ajani JA, Badgwell BD, Mansfield PF, Blum Murphy MA, Ikoma N, Ho J, Suh Y, Holliday EB, Herman JM, Minsky BD, Koay EJ, Koong A, Krishnan S, Smith GL, et al. The effect of IMRT on acute toxicity in patients with gastric cancer treated with preoperative chemoradiation. Journal of Clinical Oncology. 37: 153-153. DOI: 10.1200/Jco.2019.37.4_Suppl.153  0.32
2019 Abu-Gheida I, Patel A, Zaid M, Elganainy D, Javle MM, Raghav KPS, Vauthey J, Aloia TA, Tzeng CD, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong A, Krishnan S, et al. Outcomes and patterns of failures after hypofractionated radiation therapy for intrahepatic cholangiocarcinoma. Journal of Clinical Oncology. 37: e15609-e15609. DOI: 10.1200/Jco.2019.37.15_Suppl.E15609  0.336
2019 Levy K, Rafat M, Schueler E, Eggold JT, Wang J, Casey K, Koong A, Maxim P, Loo BW, Rankin E. Preclinical testing of ultra-rapid FLASH total abdominal irradiation demonstrates survival benefit and decreased gastrointestinal toxicity compared to conventional external beam radiation. Journal of Clinical Oncology. 37: 3092-3092. DOI: 10.1200/Jco.2019.37.15_Suppl.3092  0.341
2019 Levy K, Eggold J, Rafat M, Schuler E, Shehade H, Fregoso D, Vilches-Moure J, Koong A, Maxim P, Loo BW, Rankin E. Abstract AP25: TOTAL ABDOMINAL ULTRA-RAPID FLASH IRRADIATION DEMONSTRATES DECREASED GASTROINTESTINAL TOXICITY COMPARED TO CONVENTIONAL TOTAL ABDOMINAL IRRADIATION IN MICE Clinical Cancer Research. 25. DOI: 10.1158/1557-3265.Ovcasymp18-Ap25  0.361
2019 Hacker BC, Alves SM, Jiang D, Koong AC, Giaccia AJ, Graves EE, Rafat M. Abstract 3931: The irradiated tissue microenvironment and its role in breast cancer recurrence: Enhanced macrophage infiltration promotes tumor cell recruitment Cancer Research. 79: 3931-3931. DOI: 10.1158/1538-7445.Am2019-3931  0.569
2019 Benej M, Hong X, Vibhute S, Scott S, Wu J, Graves E, Le Q, Koong AC, Giaccia AJ, Chen C, Yu B, Papandreou I, Denko NC. Abstract 2927: Papaverine and its novel derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism Cancer Research. 79: 2927-2927. DOI: 10.1158/1538-7445.Am2019-2927  0.579
2019 Moningi S, Aliru M, Lin D, Avila S, Smani D, Koay E, Taniguchi C, Das P, Smith G, Holliday E, Cazacu I, Singh B, Bhutani M, Koong A, Herman J. Does Fiducial Marker Placement Prior to SBRT Increase the Risk of Metastatic Disease in Patients with Unresectable Pancreatic Cancer? International Journal of Radiation Oncology*Biology*Physics. 103: E31. DOI: 10.1016/S0360-3016(19)30472-9  0.305
2018 Tao R, Ager B, Lloyd S, Torgeson A, Denney M, Gaffney D, Kharofa J, Lin SH, Koong AC, Anzai Y, Hoffman JM. Hypoxia imaging in upper gastrointestinal tumors and application to radiation therapy. Journal of Gastrointestinal Oncology. 9: 1044-1053. PMID 30603123 DOI: 10.21037/Jgo.2018.09.15  0.403
2018 Benej M, Hong X, Vibhute S, Scott S, Wu J, Graves E, Le QT, Koong AC, Giaccia AJ, Yu B, Chen CS, Papandreou I, Denko NC. Erratum: Papaverine and its derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism (Proceedings of the National Academy of Sciences of the United States of America (2018) 115 (10756–10761) DOI: 10.1073/pnas.1808945115) Proceedings of the National Academy of Sciences of the United States of America. 115. PMID 30455291 DOI: 10.1073/Pnas.1818732115  0.472
2018 Colbert LE, Rebueno N, Moningi S, Beddar S, Sawakuchi GO, Herman JM, Koong AC, Das P, Holliday EB, Koay EJ, Taniguchi CM. Dose escalation for locally advanced pancreatic cancer: How high can we go? Advances in Radiation Oncology. 3: 693-700. PMID 30370371 DOI: 10.1016/J.Adro.2018.07.008  0.315
2018 Toesca DAS, Koong AJ, von Eyben R, Koong AC, Chang DT. Stereotactic body radiation therapy for adrenal gland metastases: Outcomes and toxicity. Advances in Radiation Oncology. 3: 621-629. PMID 30370363 DOI: 10.1016/J.Adro.2018.05.006  0.318
2018 Chiou SH, Dorsch M, Kusch E, Naranjo S, Kozak MM, Koong AC, Winslow MM, Grüner BM. Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance. Scientific Reports. 8: 14008. PMID 30228296 DOI: 10.1038/S41598-018-32159-X  0.365
2018 Benej M, Hong X, Vibhute S, Scott S, Wu J, Graves E, Le QT, Koong AC, Giaccia AJ, Yu B, Chen SC, Papandreou I, Denko NC. Papaverine and its derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism. Proceedings of the National Academy of Sciences of the United States of America. PMID 30201710 DOI: 10.1073/Pnas.1808945115  0.555
2018 Elganainy D, Holliday EB, Taniguchi CM, Smith GL, Shroff R, Javle M, Raghav K, Kaseb A, Aloia TA, Vauthey JN, Tzeng CD, Herman JM, Koong AC, Krishnan SX, Minsky BD, et al. Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma. Cancer Medicine. PMID 30152073 DOI: 10.1002/Cam4.1734  0.304
2018 Hunt A, Das P, Minsky BD, Koay EJ, Krishnan S, Herman JM, Taniguchi C, Koong A, Smith GL, Holliday EB. Hyperfractionated abdominal reirradiation for gastrointestinal malignancies. Radiation Oncology (London, England). 13: 143. PMID 30086784 DOI: 10.1186/S13014-018-1084-0  0.336
2018 Yurgelun MB, Chittenden AB, Morales-Oyarvide V, Rubinson DA, Dunne RF, Kozak MM, Qian ZR, Welch MW, Brais LK, Da Silva A, Bui JL, Yuan C, Li T, Li W, Masuda A, ... ... Koong AC, et al. Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 29961768 DOI: 10.1038/S41436-018-0009-5  0.323
2018 Qian Y, Von Eyben R, Liu Y, Chin FT, Miao Z, Apte S, Carter JN, Binkley MS, Pollom EL, Harris JP, Prionas ND, Kissel M, Simmons A, Diehn M, Shultz DB, ... ... Koong AC, et al. F-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated With Highly Conformal Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. PMID 29859786 DOI: 10.1016/J.Ijrobp.2018.03.045  0.342
2018 Toesca DAS, Koong AJ, Poultsides GA, Visser BC, Haraldsdottir S, Koong AC, Chang DT. Management of Borderline Resectable Pancreatic Cancer. International Journal of Radiation Oncology, Biology, Physics. 100: 1155-1174. PMID 29722658 DOI: 10.1016/J.Ijrobp.2017.12.287  0.378
2018 Fang P, Jiang W, Davuluri R, Xu C, Krishnan S, Mohan R, Koong AC, Hsu CC, Lin SH. High lymphocyte count during neoadjuvant chemoradiotherapy is associated with improved pathologic complete response in esophageal cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 29530432 DOI: 10.1016/J.Radonc.2018.02.025  0.349
2018 Yang Z, Zhang J, Jiang D, Khatri P, Solow-Cordero DE, Toesca DAS, Koumenis C, Denko NC, Giaccia AJ, Le QT, Koong AC. A Human Genome-wide RNAi Screen Reveals Diverse Modulators that Mediate IRE1α-XBP1 Activation. Molecular Cancer Research : McR. PMID 29440447 DOI: 10.1158/1541-7786.Mcr-17-0307  0.519
2018 Toesca DAS, Ibragimov B, Koong AJ, Xing L, Koong AC, Chang DT. Strategies for prediction and mitigation of radiation-induced liver toxicity. Journal of Radiation Research. PMID 29432550 DOI: 10.1093/Jrr/Rrx104  0.331
2018 Lin SH, Koong AC. Breathing New Life Into Hypoxia-Targeted Therapies for Non-Small Cell Lung Cancer. Journal of the National Cancer Institute. 110. PMID 28922792 DOI: 10.1093/Jnci/Djx163  0.303
2018 Jin W, Toesca DAS, Osmundson E, Shaffer J, Koong A, Chang DT. Can looking at density differences between liver parenchyma and oligometastatic lesions predict outcomes and toxicities in patients receiving stereotactic body radiation therapy for metastatectomy Journal of Clinical Oncology. 36: 479-479. DOI: 10.1200/Jco.2018.36.4_Suppl.479  0.327
2018 Toesca DAS, Jeffrey B, Eyben Rv, Poullos PD, Poultsides GA, Fisher GA, Visser BC, Koong A, Chang DT. Prediction of pancreatic cancer surgical outcomes and prognosis based on an objective resectability scoring system. Journal of Clinical Oncology. 36: 446-446. DOI: 10.1200/Jco.2018.36.4_Suppl.446  0.33
2018 Colbert LE, Gomez M, Todd S, Tang C, Christopherson K, Grosshans DR, Lin LL, Bird JE, Moon B, Satcher RL, Lewis VO, Koong A, Gomez DR. Implementation of a rapid access multidisciplinary bone metastases clinic to improve access to care at a large cancer center. Journal of Clinical Oncology. 36: 79-79. DOI: 10.1200/Jco.2018.36.34_Suppl.79  0.309
2018 Nambiar DK, Aguilera TA, Bloomstein JD, Jiang D, Cao H, Koong A, Le QT. Abstract 4068: Galectin-1 intensifies immunosuppression in head and neck cancer by boosting myeloid-derived suppressive cell (MDSC) expansion Cancer Research. 78: 4068-4068. DOI: 10.1158/1538-7445.Am2018-4068  0.397
2018 Toesca DAS, Wu Y, Koong A, Eyben RV, Osmundson EC, Shaffer J, Koong AC, Chang DT. Worsening of Child-Pugh Score after Stereotactic Body Radiation Therapy Significantly Impacts Survival of Patients Treated for Hepatocellular Carcinoma International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.498  0.316
2018 Koong A, Toesca DAS, Eyben RV, Koong AC, Chang DT. Single Institution Experience with Stereotactic Body Radiation Therapy for Treatment of Adrenal Gland Metastases International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.361  0.307
2018 Qian Y, Liu Y, Von Eyben R, Carter JN, Pollom EL, Harris JP, Prionas ND, Binkley MS, Simmons A, Diehn M, Chin FT, Shultz DB, Brown JM, Maxim PG, Koong AC, et al. (OA41) 18F-EF5 Pet-Based Imageable Hypoxia Predicts for Local Control in Tumors Treated With Conformal Radiotherapy International Journal of Radiation Oncology*Biology*Physics. 101: e17-e18. DOI: 10.1016/J.Ijrobp.2018.02.080  0.304
2018 Nambiar D, Aguilera TA, Bloomstein JD, Cao H, Koong AC, Le QT. Galectin-1 Orchestrates Immune Evasion in Head and Neck Cancer by Suppressing T Cell Recruitment to Tumors International Journal of Radiation Oncology Biology Physics. 100: 1314. DOI: 10.1016/J.Ijrobp.2017.12.035  0.346
2017 Rao AD, Liu Y, von Eyben R, Hsu CC, Hu C, Rosati LM, Parekh A, Ng K, Hacker-Prietz A, Zheng L, Pawlik TM, Laheru DA, Jaffee EM, Weiss MJ, Le DT, ... ... Koong AC, et al. Multiplex Proximity Ligation Assay to Identify Potential Prognostic Biomarkers for Improved Survival in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. PMID 29157747 DOI: 10.1016/J.Ijrobp.2017.10.001  0.377
2017 Mello SS, Valente LJ, Raj N, Seoane JA, Flowers BM, McClendon J, Bieging-Rolett KT, Lee J, Ivanochko D, Kozak MM, Chang DT, Longacre TA, Koong AC, Arrowsmith CH, Kim SK, et al. A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer. Cancer Cell. 32: 460-473.e6. PMID 29017057 DOI: 10.1016/J.Ccell.2017.09.007  0.348
2017 Chiou SH, Risca VI, Wang GX, Yang D, Grüner BM, Kathiria AS, Ma RK, Vaka D, Chu P, Kozak M, Castellini L, Graves EE, Kim GE, Mourrain P, Koong AC, et al. Blimp1 induces transient metastatic heterogeneity in pancreatic cancer. Cancer Discovery. PMID 28790031 DOI: 10.1158/2159-8290.Cd-17-0250  0.549
2017 Tempero MA, Malafa MP, Al-Hawary M, Asbun H, Bain A, Behrman SW, Benson AB, Binder E, Cardin DB, Cha C, Chiorean EG, Chung V, Czito B, Dillhoff M, Dotan E, ... ... Koong A, et al. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : Jnccn. 15: 1028-1061. PMID 28784865 DOI: 10.6004/Jnccn.2017.0131  0.345
2017 Toesca DA, Pollom EL, Poullos PD, Flynt L, Cui Y, Quon A, von Eyben R, Koong AC, Chang DT. Assessing local progression after stereotactic body radiation therapy for unresectable pancreatic adenocarcinoma: CT versus PET. Practical Radiation Oncology. 7: 120-125. PMID 28274396 DOI: 10.1016/J.Prro.2016.09.002  0.307
2017 Jones WE, Suh WW, Abdel-Wahab M, Abrams RA, Azad N, Das P, Dragovic J, Goodman KA, Jabbour SK, Konski AA, Koong AC, Kumar R, Lee P, Pawlik TM, Small W, et al. ACR Appropriateness Criteria® Resectable Pancreatic Cancer. American Journal of Clinical Oncology. PMID 28230650 DOI: 10.1097/Coc.0000000000000370  0.327
2017 Nambiar DK, Aguilera T, Bloomstein JD, Cao H, Koong A, Le QT. Abstract LB-180: Targeting galectin-1 in combination with radiation and immune checkpoint therapy in head and neck cancers Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-180  0.388
2017 Toesca DAS, Pollom E, Eyben RV, Koong AC, Chang DT. The Impact of Chemotherapy Regimen and Radiation Dose of Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Adenocarcinoma International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.1063  0.328
2017 Parekh A, Rosati LM, Chang DT, Goodman KA, Pawlik TM, Koong AC, Herman JM. Stereotactic body radiation for pancreatic cancer: results of an international survey of practice patterns Journal of Radiation Oncology. 6: 273-278. DOI: 10.1007/S13566-016-0267-2  0.341
2016 Toesca DA, Osmundson EC, von Eyben R, Shaffer JL, Koong AC, Chang DT. Assessment of hepatic function decline after stereotactic body radiation therapy for primary liver cancer. Practical Radiation Oncology. PMID 28343896 DOI: 10.1016/J.Prro.2016.10.003  0.302
2016 Aguilera TA, Rafat M, Castellini L, Shehade H, Kariolis MS, Hui AB, Stehr H, von Eyben R, Jiang D, Ellies LG, Koong AC, Diehn M, Rankin EB, Graves EE, Giaccia AJ. Reprogramming the immunological microenvironment through radiation and targeting Axl. Nature Communications. 7: 13898. PMID 28008921 DOI: 10.1038/Ncomms13898  0.531
2016 Kariolis MS, Miao YR, Diep A, Nash SE, Olcina MM, Jiang D, Jones DS, Kapur S, Mathews II, Koong AC, Rankin EB, Cochran JR, Giaccia AJ. Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies. The Journal of Clinical Investigation. PMID 27893463 DOI: 10.1172/Jci85610  0.515
2016 Pollom EL, Alagappan M, Park LS, Whittemore AS, Koong AC, Chang DT. Does radiotherapy still have a role in unresected biliary tract cancer? Cancer Medicine. PMID 27891822 DOI: 10.1002/Cam4.975  0.35
2016 Toesca DA, Osmundson EC, Eyben RV, Shaffer JL, Koong AC, Chang DT. Central liver toxicity after SBRT: An expanded analysis and predictive nomogram. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 27865544 DOI: 10.1016/J.Radonc.2016.10.024  0.314
2016 Rosati LM, Liu Y, Rao AD, Hsu CC, Parekh A, Ng K, Hacker-Prietz A, Zheng L, Laheru DA, Jaffee EM, Le DT, De Jesus-Acosta A, Hruban RH, Pawlik TM, Weiss MJ, ... ... Koong AC, et al. Serum Protein Expression and Associations With Conversion to Resectable Status Following Chemotherapy and Stereotactic Body Radiation Therapy in Locally Advanced Pancreatic Adenocarcinoma. International Journal of Radiation Oncology, Biology, Physics. 96: S44. PMID 27675931 DOI: 10.1016/J.Ijrobp.2016.06.117  0.347
2016 Aggarwal S, Prionas ND, Carter JN, Pradhan P, Bui JL, von Eyben R, Ho CK, Hancock SL, Soltys SG, Koong AC, Chang DT. Accuracy of Predicting Survival Outcomes in Palliative Radiation Therapy Patients. International Journal of Radiation Oncology, Biology, Physics. 96: S148-S149. PMID 27675642 DOI: 10.1016/J.Ijrobp.2016.06.360  0.308
2016 Toesca DA, Osmundson E, Shaffer J, von Eyben R, Koong AC, Chang DT. Hepatobiliary Toxicity Association With Central Biliary Tract Dose After Stereotactic Body Radiation Therapy: An Expanded Analysis. International Journal of Radiation Oncology, Biology, Physics. 96: S141-S142. PMID 27675628 DOI: 10.1016/J.Ijrobp.2016.06.344  0.3
2016 Rao AD, Liu Y, Hsu CC, Parekh A, Rosati LM, Ng K, Hacker-Prietz A, Zheng L, Pawlik TM, Laheru DA, Jaffee EM, Weiss MJ, Le DT, Hruban RH, De Jesus-Acosta A, ... ... Koong AC, et al. Multiplex Proximal Ligation Assay Identifies Potential Prognostic Biomarkers for Improved Survival in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 96: E597-E598. PMID 27675116 DOI: 10.1016/J.Ijrobp.2016.06.2126  0.367
2016 Toesca DA, Pollom E, Nwachukwu CR, von Eyben R, Koong AC, Chang DT. Reirradiation With Stereotactic Body Radiation Therapy After Prior Conventional Fractionation Radiation for Locally Recurrent Pancreatic Adenocarcinoma. International Journal of Radiation Oncology, Biology, Physics. 96: E205. PMID 27674059 DOI: 10.1016/J.Ijrobp.2016.06.1107  0.324
2016 Toesca DA, Pollom E, Nwachukwu CR, von Eyben R, Koong AC, Chang DT. The Impact of FDG Positron Emission Tomography for Assessment of Local Progression of Unresectable Pancreatic Adenocarcinoma After Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 96: E205. PMID 27674057 DOI: 10.1016/J.Ijrobp.2016.06.1106  0.303
2016 Toesca DA, Osmundson E, Shaffer J, von Eyben R, Koong AC, Chang DT. Assessment of Hepatic Function Decline After Stereotactic Body Radiation Therapy for Primary Liver Tumors Using the Albumin-Bilirubin (ALBI) Score. International Journal of Radiation Oncology, Biology, Physics. 96: E203-E204. PMID 27674053 DOI: 10.1016/J.Ijrobp.2016.06.1102  0.322
2016 Carter JN, Aggarwal S, Radish K, Allen JR, Koong AC, Chang DT, Loo BW, Diehn M, Kunz PL, Gensheimer MF. Effectiveness of Radiation Therapy for Low- to Intermediate-Grade Neuroendocrine Tumors. International Journal of Radiation Oncology, Biology, Physics. 96: E202-E203. PMID 27674052 DOI: 10.1016/J.Ijrobp.2016.06.1100  0.362
2016 Nwachukwu CR, Toesca DA, Pollom E, von Eyben R, Chang DT, Koong AC. Stereotactic Body Radiation Therapy After Surgical Resection for Locally Recurrent Pancreatic Adenocarcinoma. International Journal of Radiation Oncology, Biology, Physics. 96: E158. PMID 27673930 DOI: 10.1016/J.Ijrobp.2016.06.989  0.32
2016 Chin AL, Aggarwal S, Bush K, von Eyben R, Koong AC, Chang DT. Impact of Spleen and Thoracic Spine Irradiation on Acute Hematologic Toxicity During Chemoradiation for Esophageal Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: E147. PMID 27673902 DOI: 10.1016/J.Ijrobp.2016.06.961  0.309
2016 Jiang D, Lynch C, Medeiros BC, Liedtke M, Bam R, Tam AB, Yang Z, Alagappan M, Abidi P, Le QT, Giaccia AJ, Denko NC, Niwa M, Koong AC. Identification of Doxorubicin as an Inhibitor of the IRE1α-XBP1 Axis of the Unfolded Protein Response. Scientific Reports. 6: 33353. PMID 27634301 DOI: 10.1038/Srep33353  0.529
2016 Rao AD, Sugar EA, Chang DT, Goodman KA, Hacker-Prietz A, Rosati LM, Columbo L, O'Reilly E, Fisher GA, Zheng L, Pai JS, Griffith ME, Laheru DA, Iacobuzio-Donahue CA, Wolfgang CL, ... Koong A, et al. Patient-reported outcomes of a multicenter phase 2 study investigating gemcitabine and stereotactic body radiation therapy in locally advanced pancreatic cancer. Practical Radiation Oncology. PMID 27552809 DOI: 10.1016/J.Prro.2016.05.005  0.349
2016 Cui Y, Song J, Pollom E, Alagappan M, Shirato H, Chang DT, Koong AC, Li R. Quantitative Analysis of (18)F-Fluorodeoxyglucose Positron Emission Tomography Identifies Novel Prognostic Imaging Biomarkers in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 96: 102-9. PMID 27511850 DOI: 10.1016/J.Ijrobp.2016.04.034  0.341
2016 Sun RC, Koong A, Giaccia A, Denko NC. Measuring the Impact of Microenvironmental Conditions on Mitochondrial Dehydrogenase Activity in Cultured Cells. Advances in Experimental Medicine and Biology. 899: 113-20. PMID 27325264 DOI: 10.1007/978-3-319-26666-4_7  0.463
2016 Jiang D, Tam A, Alagappan M, Hay MP, Gupta A, Kozak M, Solow-Cordero DE, Lum PY, Denko N, Giaccia AJ, Le QT, Niwa M, Koong AC. Acridine Derivatives as Inhibitors of the IRE1α-XBP1 Pathway Cytotoxic to Human Multiple Myeloma. Molecular Cancer Therapeutics. PMID 27307600 DOI: 10.1158/1535-7163.Mct-15-1023  0.473
2016 Shultz DB, Pai J, Chiu W, Ng K, Hellendag MG, Heestand G, Chang DT, Tu D, Moore MJ, Parulekar WR, Koong AC. A Novel Biomarker Panel Examining Response to Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy in NCIC Clinical Trials Group PA.3. Plos One. 11: e0147995. PMID 26808546 DOI: 10.1371/Journal.Pone.0147995  0.337
2016 Alagappan M, Pollom EL, von Eyben R, Kozak MM, Aggarwal S, Poultsides GA, Koong AC, Chang DT. Albumin and Neutrophil-Lymphocyte Ratio (NLR) Predict Survival in Patients With Pancreatic Adenocarcinoma Treated With SBRT. American Journal of Clinical Oncology. PMID 26757436 DOI: 10.1097/Coc.0000000000000263  0.309
2016 Ager C, Reilley M, Nicholas C, Bartkowiak T, Jaiswal A, Curran M, Albershardt TC, Bajaj A, Archer JF, Reeves RS, Ngo LY, Berglund P, ter Meulen J, Denis C, Ghadially H, ... ... Koong A, et al. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two Journal For Immunotherapy of Cancer. 4. DOI: 10.1186/S40425-016-0173-6  0.468
2015 Lu SL, Hsu FM, Tsai CL, Wu JK, Lee JM, Huang PM, Hsu CH, Koong AC, Chang DT, Chia-Hsien Cheng J. Serum Transforming Growth Factor-β1 Change After Neoadjuvant Chemoradiation Therapy Is Associated With Postoperative Pulmonary Complications in Esophageal Cancer Patients Undergoing Combined Modality Therapy. International Journal of Radiation Oncology, Biology, Physics. PMID 26475065 DOI: 10.1016/J.Ijrobp.2015.08.035  0.327
2015 Kozak MM, Anderson EM, von Eyben R, Pai JS, Poultsides GA, Visser BC, Norton JA, Koong AC, Chang DT. Statin and Metformin Use Prolongs Survival in Patients With Resectable Pancreatic Cancer. Pancreas. PMID 26474429 DOI: 10.1097/Mpa.0000000000000470  0.331
2015 Russo S, Blackstock AW, Herman JM, Abdel-Wahab M, Azad N, Das P, Goodman KA, Hong TS, Jabbour SK, Jones WE, Konski AA, Koong AC, Kumar R, Rodriguez-Bigas M, Small W, et al. ACR Appropriateness Criteria® Local Excision in Early Stage Rectal Cancer. American Journal of Clinical Oncology. 38: 520-5. PMID 26371522 DOI: 10.1097/Coc.0000000000000197  0.317
2015 Pollom EL, Koong AC, Ko AH. Treatment Approaches to Locally Advanced Pancreatic Adenocarcinoma. Hematology/Oncology Clinics of North America. 29: 741-59. PMID 26226908 DOI: 10.1016/J.Hoc.2015.04.005  0.347
2015 Pollom EL, Deng L, Pai RK, Brown JM, Giaccia A, Loo BW, Shultz DB, Le QT, Koong AC, Chang DT. Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 92: 568-576. PMID 26068491 DOI: 10.1016/J.Ijrobp.2015.02.016  0.526
2015 Le QT, Shirato H, Giaccia AJ, Koong AC. Emerging Treatment Paradigms in Radiation Oncology. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 3393-401. PMID 25991820 DOI: 10.1158/1078-0432.Ccr-14-1191  0.527
2015 Kozak MM, von Eyben R, Pai JS, Anderson EM, Welton ML, Shelton AA, Kin C, Koong AC, Chang DT. The Prognostic Significance of Pretreatment Hematologic Parameters in Patients Undergoing Resection for Colorectal Cancer. American Journal of Clinical Oncology. PMID 25756348 DOI: 10.1097/COC.0000000000000183  0.33
2015 Kozak MM, von Eyben R, Pai J, Vossler SR, Limaye M, Jayachandran P, Anderson EM, Shaffer JL, Longacre T, Pai RK, Koong AC, Chang DT. Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer. Journal of Clinical Pathology. 68: 341-5. PMID 25681512 DOI: 10.1136/Jclinpath-2014-202660  0.301
2015 Osmundson EC, Wu Y, Luxton G, Bazan JG, Koong AC, Chang DT. Predictors of toxicity associated with stereotactic body radiation therapy to the central hepatobiliary tract International Journal of Radiation Oncology Biology Physics. 91: 986-994. PMID 25659885 DOI: 10.1016/J.Ijrobp.2014.11.028  0.317
2015 Herman JM, Chang DT, Goodman KA, Dholakia AS, Raman SP, Hacker-Prietz A, Iacobuzio-Donahue CA, Griffith ME, Pawlik TM, Pai JS, O'Reilly E, Fisher GA, Wild AT, Rosati LM, Zheng L, ... ... Koong AC, et al. Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma. Cancer. 121: 1128-37. PMID 25538019 DOI: 10.1002/Cncr.29161  0.363
2015 Alagappan M, Pollom EL, Eyben Rv, Kunz PL, Fisher GA, Ford JM, Poultsides GA, Visser BC, Norton JA, Kamaya A, Columbo LA, Koong A, Chang DT. Pretreatment lab values to predict overall survival in patients with primary unresectable pancreatic adenocarcinoma treated with SBRT. Journal of Clinical Oncology. 33: 433-433. DOI: 10.1200/Jco.2015.33.3_Suppl.433  0.346
2015 Le QT, Shirato H, Giaccia AJ, Koong AC. Emerging treatment paradigms in radiation oncology Clinical Cancer Research. 21: 3393-3401. DOI: 10.1158/1078-0432.CCR-14-1191  0.473
2015 Rao AD, Chang DT, Parekh A, Rosati LM, Moningi S, Blackford A, Hacker-Prietz A, Wild AT, Zheng L, Weiss M, Pawlik TM, Asrari F, Fisher G, Laheru DA, Wolfgang CL, ... Koong AC, et al. Multiplex proximity ligation assay to identify a biomarker panel for prognosis in unresectable pancreatic cancer patients treated with stereotactic body radiation therapy International Journal of Radiation Oncology Biology Physics. DOI: 10.1016/J.Ijrobp.2015.08.042  0.366
2015 Shaffer J, Koong AC, Chang DT. CEA as a Predictor of Pathologic Tumor Response Following Long Course Neoadjuvant Chemoradiation Therapy for Rectal Cancer International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.978  0.373
2015 Parekh A, Rosati LM, Chang DT, Goodman KA, Koong AC, Herman JM. Stereotactic Body Radiation for Pancreatic Cancer: Results of an International Survey of Practice Patterns International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.884  0.333
2015 Cui Y, Song J, Pollom E, Shirato H, Chang D, Koong A, Li R. Radiomic Analysis of FDG-PET Identifies Novel Prognostic Imaging Biomarkers in Locally Advanced Pancreatic Cancer Patients Treated With SBRT International Journal of Radiation Oncology*Biology*Physics. 93: S4-S5. DOI: 10.1016/J.Ijrobp.2015.07.017  0.314
2014 Herman JM, Koong AC. Stereotactic body radiation therapy: a new standard option for pancreatic cancer? Journal of the National Comprehensive Cancer Network : Jnccn. 12: 1489-93. PMID 25313185 DOI: 10.6004/Jnccn.2014.0143  0.385
2014 Kuo P, Bratman SV, Shultz DB, von Eyben R, Chan C, Wang Z, Say C, Gupta A, Loo BW, Giaccia AJ, Koong AC, Diehn M, Le QT. Galectin-1 mediates radiation-related lymphopenia and attenuates NSCLC radiation response. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 5558-69. PMID 25189484 DOI: 10.1158/1078-0432.Ccr-14-1138  0.55
2014 Moningi S, Marciscano AE, Rosati LM, Ng SK, Teboh Forbang R, Jackson J, Chang DT, Koong AC, Herman JM. Stereotactic body radiation therapy in pancreatic cancer: the new frontier. Expert Review of Anticancer Therapy. 14: 1461-75. PMID 25183386 DOI: 10.1586/14737140.2014.952286  0.408
2014 Xiao N, Lin Y, Cao H, Sirjani D, Giaccia AJ, Koong AC, Kong CS, Diehn M, Le QT. Neurotrophic factor GDNF promotes survival of salivary stem cells. The Journal of Clinical Investigation. 124: 3364-77. PMID 25036711 DOI: 10.1172/Jci74096  0.524
2014 Dholakia AS, Chaudhry M, Leal JP, Chang DT, Raman SP, Hacker-Prietz A, Su Z, Pai J, Oteiza KE, Griffith ME, Wahl RL, Tryggestad E, Pawlik T, Laheru DA, Wolfgang CL, ... Koong AC, et al. Baseline metabolic tumor volume and total lesion glycolysis are associated with survival outcomes in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 89: 539-46. PMID 24751410 DOI: 10.1016/J.Ijrobp.2014.02.031  0.376
2014 Trakul N, Koong AC, Chang DT. Stereotactic body radiotherapy in the treatment of pancreatic cancer. Seminars in Radiation Oncology. 24: 140-7. PMID 24635871 DOI: 10.1016/J.Semradonc.2013.11.008  0.364
2014 Cheng JC, Graber MS, Hsu FM, Tsai CL, Castaneda L, Lee JM, Chang DT, Koong AC. High serum levels of vascular endothelial growth factor-A and transforming growth factor-β1 before neoadjuvant chemoradiotherapy predict poor outcomes in patients with esophageal squamous cell carcinoma receiving combined modality therapy. Annals of Surgical Oncology. 21: 2361-8. PMID 24623035 DOI: 10.1245/S10434-014-3611-Z  0.324
2014 Pollom EL, Alagappan M, Chan C, Shultz D, Kunz PL, Koong A, Chang DT. Outcomes and toxicity of SBRT for patients with unresectable pancreatic adenocarcinoma. Journal of Clinical Oncology. 32: 317-317. DOI: 10.1200/Jco.2014.32.3_Suppl.317  0.31
2014 Dholakia AS, Chang DT, Goodman KA, Sugar E, Hacker-Prietz A, Columbo LA, Griffith ME, Wild AT, Moningi S, Pawlik TM, Fisher GA, Ellsworth SG, Koong A, Herman JM. Effects of gemcitabine and stereotactic body radiotherapy on quality of life in locally advanced pancreatic cancer. Journal of Clinical Oncology. 32: 278-278. DOI: 10.1200/Jco.2014.32.3_Suppl.278  0.349
2014 Dholakia AS, Chaudhry MA, Leal JP, Chang DT, Raman SP, Su Z, Hacker-Prietz A, Pai J, Griffith ME, Wahl RL, Tryggestad E, Pawlik TM, Laheru DA, Wolfgang CL, Koong A, et al. Pre-SBRT metabolic tumor volume and total lesion glycolysis to predict survival in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapy. Journal of Clinical Oncology. 32: 189-189. DOI: 10.1200/Jco.2014.32.3_Suppl.189  0.343
2014 Heestand GM, Murphy JD, Moughan J, Regine W, Luo J, Graber MS, Kunz PL, Fisher GA, Guha C, Lin B, Mowat RB, Gaur R, Buyyounouski MK, Chen Y, Chang DT, ... Koong A, et al. A novel biomarker panel examining response to adjuvant pancreatic cancer therapy in RTOG 9704. Journal of Clinical Oncology. 32: 176-176. DOI: 10.1200/Jco.2014.32.3_Suppl.176  0.346
2014 Picozzi VJ, Pipas JM, Koong A, Giaccia A, Bahary N, Krishnamurthi SS, Lopez CD, O'Dwyer PJ, Modelska K, Carney M, Hernandez H, Chou J, Lee T, Zhong M, Porter S, et al. FG-3019, a human monoclonal antibody to connective tissue growth factor (CTGF), with gemcitabine/erlotinib (G/E) in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC). Journal of Clinical Oncology. 32: 4138-4138. DOI: 10.1200/Jco.2014.32.15_Suppl.4138  0.501
2014 Kuo P, Bratman S, Shultz D, Eyben Rv, Chan C, Wang Z, Say C, Gupta A, Loo BW, Giaccia A, Koong A, Diehn M, Le Q. Abstract 848: Galectin-1 mediates radiation-related lymphopenia in non-small cell lung cancer and attenuates tumor radiation response Cancer Research. 74: 848-848. DOI: 10.1158/1538-7445.Am2014-848  0.583
2014 Osmundson E, Newman A, Bratman S, Klass D, Zhou L, Pai J, Longacre T, Alizadeh A, Koong A, Diehn M. Circulating Tumor DNA as a Biomarker for Pancreatic Adenocarcinoma International Journal of Radiation Oncology*Biology*Physics. 90: S816-S817. DOI: 10.1016/J.Ijrobp.2014.05.2354  0.307
2014 Rafat M, Bazalova M, Palma B, Kozak M, Jiang D, Dunning M, McCormick D, Nelson J, Hemsing E, Lartey F, Graves E, Koong A, Maxim P, Loo B. Impact of Very Rapid Irradiation on Clonogenic Survival International Journal of Radiation Oncology*Biology*Physics. 90: S790. DOI: 10.1016/J.Ijrobp.2014.05.2283  0.313
2014 Shaffer J, Feng MU, Pollom E, Stenmark MH, Tang M, Monroe AT, Merrell KW, Lee P, Olivier KR, Koong AC, Chang DT. Pooled Analysis of Stereotactic Body Radiation Therapy for Liver Tumors: Results From 5 Institutions International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1223  0.351
2014 Chang DT, Shaffer J, Pollom E, Stenmark MH, Tang M, Merrell KW, Lee P, Olivier KR, Koong AC, Feng MU. Pooled Analysis of Liver Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Results From a Multi-institution Study International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1211  0.327
2014 Shaffer J, Feng MU, Pollom E, Stenmark MH, Tang M, Monroe AT, Lee P, Merrell KW, Olivier KR, Koong AC, Chang DT. Pooled Analysis of Liver Stereotactic Body Radiation Therapy for Colorectal Metastases: Results From 5 Institutions International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1210  0.328
2014 Moningi S, Dholakia AS, Raman S, Hacker-Prietz A, Pawlik T, Zheng L, Pollom E, Weiss M, Laheru D, Wolfgang C, Chang DT, Koong AC, Herman JM. Surgical Outcomes Following Chemotherapy and Stereotactic Body Radiation Therapy in Patients With Borderline and Unresectable Pancreatic Cancer International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1186  0.359
2013 Wild AT, Hiniker SM, Chang DT, Tran PT, Khashab MA, Limaye MR, Laheru DA, Le DT, Kumar R, Pai JS, Hargens B, Sharabi AB, Shin EJ, Zheng L, Pawlik TM, ... ... Koong AC, et al. Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions. Journal of Gastrointestinal Oncology. 4: 343-51. PMID 24294505 DOI: 10.3978/J.Issn.2078-6891.2013.044  0.332
2013 Li R, Han B, Meng B, Maxim PG, Xing L, Koong AC, Diehn M, Loo BW. Clinical implementation of intrafraction cone beam computed tomography imaging during lung tumor stereotactic ablative radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 87: 917-23. PMID 24113060 DOI: 10.1016/J.Ijrobp.2013.08.015  0.319
2013 Xiao N, Cao H, Chen CH, Kong CS, Ali R, Chan C, Sirjani D, Graves E, Koong A, Giaccia A, Mochly-Rosen D, Le QT. A novel aldehyde dehydrogenase-3 activator (Alda-89) protects submandibular gland function from irradiation without accelerating tumor growth. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 4455-64. PMID 23812668 DOI: 10.1158/1078-0432.Ccr-13-0127  0.533
2013 Hong JC, Murphy JD, Wang SJ, Koong AC, Chang DT. Chemoradiotherapy before and after surgery for locally advanced esophageal cancer: a SEER-Medicare analysis. Annals of Surgical Oncology. 20: 3999-4007. PMID 23800897 DOI: 10.1245/S10434-013-3072-9  0.318
2013 Taniguchi CM, Murphy JD, Eclov N, Atwood TF, Kielar KN, Christman-Skieller C, Mok E, Xing L, Koong AC, Chang DT. Dosimetric analysis of organs at risk during expiratory gating in stereotactic body radiation therapy for pancreatic cancer. International Journal of Radiation Oncology, Biology, Physics. 85: 1090-5. PMID 23273994 DOI: 10.1016/J.Ijrobp.2012.07.2366  0.338
2013 Bazan JG, Koong AC, Kapp DS, Quon A, Graves EE, Loo BW, Chang DT. Metabolic tumor volume predicts disease progression and survival in patients with squamous cell carcinoma of the anal canal. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 27-32. PMID 23236018 DOI: 10.2967/Jnumed.112.109470  0.368
2013 Sayers CM, Papandreou I, Guttmann DM, Maas NL, Diehl JA, Witze ES, Koong AC, Koumenis C. Identification and characterization of a potent activator of p53-independent cellular senescence via a small-molecule screen for modifiers of the integrated stress response. Molecular Pharmacology. 83: 594-604. PMID 23229510 DOI: 10.1124/Mol.112.081810  0.335
2013 Graber MS, Cheng JC, Hsu F, Koong A. Association of low serum levels of transforming growth factor β1 (TGF-β1) and high levels of vascular endothelial growth factor-A (VEGF-A) following neoadjuvant chemoradiotherapy with poor outcome in esophageal cancer patients receiving combined modality therapy: A preliminary analysis using proximity ligation assay. Journal of Clinical Oncology. 31: 80-80. DOI: 10.1200/Jco.2013.31.4_Suppl.80  0.309
2013 Picozzi VJ, Pipas JM, Koong A, Giaccia A, Bahary N, Krishnamurthi SS, Lopez CD, O'Dwyer PJ, Modelska K, Poolman V, Chou J, Zhong M, Porter S, Neff T, Valone F. FG-3019, a human monoclonal antibody to CTGF, with gemcitabine/erlotinib in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma. Journal of Clinical Oncology. 31: 213-213. DOI: 10.1200/Jco.2013.31.4_Suppl.213  0.488
2013 Shaffer J, Koong AC, Chang DT. Predicting Liver Volume Changes After Stereotactic Body Radiation Therapy for Liver Tumors International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.850  0.316
2013 Dholakia AS, Chang DT, Goodman KA, Raman SP, Leal JP, Laheru DA, Wolfgang CL, Chaudhry M, Koong AC, Herman J. 18Flurodeoxyglucose-PET Baseline Avidity Predicts for Inferior Outcomes in Patients With Locally-Advanced Pancreatic Cancer Treated With Gemcitabine and Stereotactic Body Radiation Therapy International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.810  0.354
2013 Chan C, Shultz DB, Shaffer JL, Koong AC, Chang DT. Anemia During Radiation Therapy Correlates With Outcomes in Pancreatic Cancer International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.800  0.337
2013 Pai J, Chiu W, Shultz DB, Graber M, Columbo L, Wild A, Kumar R, Herman JM, Chang DT, Koong AC. Plasma SPARC Following Stereotactic Body Radiation Therapy (SBRT) Predicts for Progression-Free Survival in Locally-Advanced Pancreatic Cancer International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.1771  0.346
2013 Dholakia AS, Chang DT, Goodman KA, Raman SP, Hacker-Prietz A, Griffith ME, Colombo L, Laheru DA, Koong AC, Herman JM. A Phase 2 Multicenter Study to Evaluate Gemcitabine and Fractionated Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Adenocarcinoma International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.077  0.317
2013 Trakul N, Koong AC, Chang DT. The role of adjuvant chemoradiation in the treatment of pancreatic cancer Journal of Radiation Oncology. 2: 391-400. DOI: 10.1007/S13566-013-0121-8  0.34
2012 Hart LS, Cunningham JT, Datta T, Dey S, Tameire F, Lehman SL, Qiu B, Zhang H, Cerniglia G, Bi M, Li Y, Gao Y, Liu H, Li C, Maity A, ... ... Koong A, et al. ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth. The Journal of Clinical Investigation. 122: 4621-34. PMID 23143306 DOI: 10.1172/Jci62973  0.328
2012 Jones WE, Thomas CR, Herman JM, Abdel-Wahab M, Azad N, Blackstock W, Das P, Goodman KA, Hong TS, Jabbour SK, Konski AA, Koong AC, Rodriguez-Bigas M, Small W, Zook J, et al. ACR appropriateness criteria®  resectable rectal cancer. Radiation Oncology (London, England). 7: 161. PMID 23006527 DOI: 10.1186/1748-717X-7-161  0.34
2012 Daly ME, Kapp DS, Maxim PG, Welton ML, Tran PT, Koong AC, Chang DT. Orthovoltage intraoperative radiotherapy for locally advanced and recurrent colorectal cancer. Diseases of the Colon and Rectum. 55: 695-702. PMID 22595850 DOI: 10.1097/Dcr.0B013E31824D464C  0.308
2012 Chang DT, Pai RK, Rybicki LA, Dimaio MA, Limaye M, Jayachandran P, Koong AC, Kunz PA, Fisher GA, Ford JM, Welton M, Shelton A, Ma L, Arber DA, Pai RK. Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 25: 1128-39. PMID 22481281 DOI: 10.1038/Modpathol.2012.61  0.316
2012 Bazan JG, Luxton G, Mok EC, Koong AC, Chang DT. Normal tissue complication probability modeling of acute hematologic toxicity in patients treated with intensity-modulated radiation therapy for squamous cell carcinoma of the anal canal International Journal of Radiation Oncology Biology Physics. 84: 700-706. PMID 22414279 DOI: 10.1016/J.Ijrobp.2011.12.072  0.321
2012 Jayachandran P, Pai RK, Quon A, Graves E, Krakow TE, La T, Loo BW, Koong AC, Chang DT. Postchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancer. International Journal of Radiation Oncology, Biology, Physics. 84: 471-7. PMID 22381904 DOI: 10.1016/J.Ijrobp.2011.12.029  0.318
2012 Trakul N, Koong AC, Maxim PG, Chang DT. Modern radiation therapy techniques for pancreatic cancer. Gastroenterology Clinics of North America. 41: 223-35. PMID 22341260 DOI: 10.1016/J.Gtc.2011.12.011  0.387
2012 Song S, Hong JC, McDonnell SE, Koong AC, Minsky BD, Chang DT, Liauw SL. Combined modality therapy for rectal cancer: the relative value of posttreatment versus pretreatment CEA as a prognostic marker for disease recurrence. Annals of Surgical Oncology. 19: 2471-6. PMID 22327251 DOI: 10.1245/S10434-012-2266-X  0.347
2012 Abelson JA, Murphy JD, Minn AY, Chung M, Fisher GA, Ford JM, Kunz P, Norton JA, Visser BC, Poultsides GA, Koong AC, Chang DT. Intensity-modulated radiotherapy for pancreatic adenocarcinoma. International Journal of Radiation Oncology, Biology, Physics. 82: e595-601. PMID 22197234 DOI: 10.1016/J.Ijrobp.2011.09.035  0.333
2012 Ren Y, Fleischmann D, Foygel K, Molvin L, Lutz AM, Koong AC, Jeffrey RB, Tian L, Willmann JK. Antiangiogenic and radiation therapy: early effects on in vivo computed tomography perfusion parameters in human colon cancer xenografts in mice. Investigative Radiology. 47: 25-32. PMID 22178893 DOI: 10.1097/Rli.0B013E31823A82F6  0.328
2012 Piccione EC, Lieu TJ, Gentile CF, Williams TR, Connolly AJ, Godwin AK, Koong AC, Wong AJ. A novel epidermal growth factor receptor variant lacking multiple domains directly activates transcription and is overexpressed in tumors. Oncogene. 31: 2953-67. PMID 21986942 DOI: 10.1038/Onc.2011.465  0.327
2012 Murphy JD, Chang DT, Abelson J, Daly ME, Yeung HN, Nelson LM, Koong AC. Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer. Cancer. 118: 1119-29. PMID 21773972 DOI: 10.1002/Cncr.26365  0.308
2012 Herman JM, Chang DT, Goodman KA, Wild AT, Laheru D, Zheng L, Diaz LA, Le DT, Raman SP, Leal JP, Chaudhry MA, Sugar E, Columbo LA, Tom A, Limaye MR, ... ... Koong A, et al. A phase II multi-institutional study to evaluate gemcitabine and fractionated stereotactic body radiotherapy for unresectable, locally advanced pancreatic adenocarcinoma. Journal of Clinical Oncology. 30: 4045-4045. DOI: 10.1200/Jco.2012.30.15_Suppl.4045  0.332
2012 Sayers CM, Koong AC, Koumenis C. Abstract 4994: An integrated stress response activator causes cellular senescence and inhibits growth in multiple tumor cell types Cancer Research. 72: 4994-4994. DOI: 10.1158/1538-7445.Am2012-4994  0.334
2012 Wild A, Hiniker SM, Limaye MR, Chang DT, Laheru DA, Tran PT, Pawlik TM, Wolfgang CL, Koong AC, Herman JM. SBRT as a Novel Treatment Option for Locally Recurrent Pancreatic Cancer After Failure of Definitive Multimodality Therapy: A Multi-institutional Case Series International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.847  0.318
2012 Chang DT, Swaminath A, Kozak M, Weintraub J, Koong AC, Kim J, Dinniwell R, Brierley J, Kavanagh BD, Dawson LA, Schefter TE. Erratum: Stereotactic body radiotherapy for colorectal liver metastases: A pooled analysis (Cancer (2011) 117 (4060-9)) Cancer. 118. DOI: 10.1002/Cncr.26583  0.303
2011 Daly ME, Murphy JD, Mok E, Christman-Skieller C, Koong AC, Chang DT. Rectal and bladder deformation and displacement during preoperative radiotherapy for rectal cancer: Are current margin guidelines adequate for conformal therapy? Practical Radiation Oncology. 1: 85-94. PMID 24673921 DOI: 10.1016/J.Prro.2010.11.006  0.31
2011 Loo BW, Chang JY, Dawson LA, Kavanagh BD, Koong AC, Senan S, Timmerman RD. Stereotactic ablative radiotherapy: what's in a name? Practical Radiation Oncology. 1: 38-9. PMID 24673868 DOI: 10.1016/J.Prro.2010.07.001  0.302
2011 Minn AY, Koong AC, Chang DT. Stereotactic body radiation therapy for gastrointestinal malignancies. Frontiers of Radiation Therapy and Oncology. 43: 412-27. PMID 21625166 DOI: 10.1159/000322505  0.382
2011 Schellenberg D, Kim J, Christman-Skieller C, Chun CL, Columbo LA, Ford JM, Fisher GA, Kunz PL, Van Dam J, Quon A, Desser TS, Norton J, Hsu A, Maxim PG, Xing L, ... ... Koong AC, et al. Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer. International Journal of Radiation Oncology, Biology, Physics. 81: 181-8. PMID 21549517 DOI: 10.1016/J.Ijrobp.2010.05.006  0.348
2011 Banh A, Zhang J, Cao H, Bouley DM, Kwok S, Kong C, Giaccia AJ, Koong AC, Le QT. Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis. Cancer Research. 71: 4423-31. PMID 21546572 DOI: 10.1158/0008-5472.Can-10-4157  0.554
2011 Chang DT, Swaminath A, Kozak M, Weintraub J, Koong AC, Kim J, Dinniwell R, Brierley J, Kavanagh BD, Dawson LA, Schefter TE. Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis. Cancer. 117: 4060-9. PMID 21432842 DOI: 10.1002/Cncr.25997  0.307
2011 Bazan JG, Hara W, Hsu A, Kunz PA, Ford J, Fisher GA, Welton ML, Shelton A, Kapp DS, Koong AC, Goodman KA, Chang DT. Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal. Cancer. 117: 3342-51. PMID 21287530 DOI: 10.1002/Cncr.25901  0.321
2011 Papandreou I, Denko NC, Olson M, Van Melckebeke H, Lust S, Tam A, Solow-Cordero DE, Bouley DM, Offner F, Niwa M, Koong AC. Identification of an Ire1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma. Blood. 117: 1311-4. PMID 21081713 DOI: 10.1182/Blood-2010-08-303099  0.307
2011 Butler PD, Wang Z, Ly DP, Longaker MT, Koong AC, Yang GP. Unfolded protein response regulation in keloid cells. The Journal of Surgical Research. 167: 151-7. PMID 19631342 DOI: 10.1016/J.Jss.2009.04.036  0.31
2011 Romero-Ramirez L, Cao H, Regalado MP, Kambham N, Siemann D, Kim JJ, Le QT, Koong AC. X box-binding protein 1 regulates angiogenesis in human pancreatic adenocarcinomas. Translational Oncology. 2: 31-8. PMID 19252749 DOI: 10.1593/Tlo.08211  0.392
2011 Koumenis C, Zhang H, Bi M, Lehman SL, Datta T, Liu H, Thomas-Tikhonenko A, Koong A, Fuchs SY, Diehl JA, Ruggero D. Abstract SY06-02: Activation of the UPR by c-Myc promotes transformation and tumorigenesis via cytoprotective autophagy Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Sy06-02  0.355
2011 Hart LS, Cunningham T, Datta T, Liu H, Koong AC, Fuchs S, Diehl JA, Ruggero D, Koumenis C. Abstract 2078: PERK-mediated autophagy promotes Myc-induced transformation and tumorigenesis Cancer Research. 71: 2078-2078. DOI: 10.1158/1538-7445.Am2011-2078  0.361
2011 Lehman SL, Sayers CM, Ye J, Hart LS, Ayeni DO, Koong A, Koumenis C. Abstract 2072: The role of the integrated stress response proteins GCN2 and ATF4 in autophagy and tumor migration Cancer Research. 71: 2072-2072. DOI: 10.1158/1538-7445.Am2011-2072  0.356
2011 Zhang J, Banh A, Jayachandran P, Wollman R, Solow-Codero DE, Meyer T, Le Q, Koong AC. Abstract 2068: A genome-wide siRNA screen reveals various modulators of the IRE1-XBP-1 signaling branch of the unfolded protein response Cancer Research. 71: 2068-2068. DOI: 10.1158/1538-7445.Am2011-2068  0.344
2011 Banh A, Zhang J, Cao H, Bouley D, Kwok S, Kong C, Giaccia A, Koong A, Le Q. Abstract 1557: Tumor Galectin-1 mediates lung cancer growth and metastasis through immunoregulation of T-cell apoptosis Cancer Research. 71: 1557-1557. DOI: 10.1158/1538-7445.Am2011-1557  0.561
2011 Banh A, Zhang J, Cao H, Bouley D, Kwok S, Kong C, Giaccia A, Koong A, Le Q. 255 INVITED Targeting Galectin-1, a Hypoxia Induced Protein, in Non-Small Cell Lung Cancers European Journal of Cancer. 47. DOI: 10.1016/S0959-8049(11)70470-1  0.437
2011 Vossler SR, Bavan B, Kunz P, Ford JM, Fisher GA, Whyte R, Koong AC, Chang DT. Multimodality Therapy for Esophageal Cancer: The Benefit of Chemoradiation International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.497  0.317
2011 Atwood T, Mok E, Lo A, Xing L, Koong A, Chang D. Dosimetric Comparison of RapidArc versus CyberKnife for Stereotactic Body Radiation Therapy for Pancreatic Cancer International Journal of Radiation Oncology*Biology*Physics. 81: S345-S346. DOI: 10.1016/J.Ijrobp.2011.06.1827  0.348
2010 Bachireddy P, Tseng D, Horoschak M, Chang DT, Koong AC, Kapp DS, Tran PT. Orthovoltage intraoperative radiation therapy for pancreatic adenocarcinoma. Radiation Oncology (London, England). 5: 105. PMID 21059255 DOI: 10.1186/1748-717X-5-105  0.323
2010 Chang DT, Chapman CH, Norton JA, Visser B, Fisher GA, Kunz P, Ford JM, Koong AC, Pai RK. Expression of p16(INK4A) but not hypoxia markers or poly adenosine diphosphate-ribose polymerase is associated with improved survival in patients with pancreatic adenocarcinoma. Cancer. 116: 5179-87. PMID 20665497 DOI: 10.1002/Cncr.25481  0.351
2010 Goodman KA, Wiegner EA, Maturen KE, Zhang Z, Mo Q, Yang G, Gibbs IC, Fisher GA, Koong AC. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. International Journal of Radiation Oncology, Biology, Physics. 78: 486-93. PMID 20350791 DOI: 10.1016/J.Ijrobp.2009.08.020  0.327
2010 Courter D, Cao H, Kwok S, Kong C, Banh A, Kuo P, Bouley DM, Vice C, Brustugun OT, Denko NC, Koong AC, Giaccia A, Le QT. The RGD domain of human osteopontin promotes tumor growth and metastasis through activation of survival pathways. Plos One. 5: e9633. PMID 20224789 DOI: 10.1371/Journal.Pone.0009633  0.524
2010 Niu G, Sun X, Cao Q, Courter D, Koong A, Le QT, Gambhir SS, Chen X. Cetuximab-based immunotherapy and radioimmunotherapy of head and neck squamous cell carcinoma Clinical Cancer Research. 16: 2095-2105. PMID 20215534 DOI: 10.1158/1078-0432.Ccr-09-2495  0.379
2010 Park WG, Yan BM, Schellenberg D, Kim J, Chang DT, Koong A, Patalano C, Van Dam J. EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer: 50 successful cases without fluoroscopy. Gastrointestinal Endoscopy. 71: 513-8. PMID 20189509 DOI: 10.1016/J.Gie.2009.10.030  0.349
2010 Schellenberg D, Quon A, Minn AY, Graves EE, Kunz P, Ford JM, Fisher GA, Goodman KA, Koong AC, Chang DT. 18Fluorodeoxyglucose PET is prognostic of progression-free and overall survival in locally advanced pancreas cancer treated with stereotactic radiotherapy. International Journal of Radiation Oncology, Biology, Physics. 77: 1420-5. PMID 20056345 DOI: 10.1016/J.Ijrobp.2009.06.049  0.32
2010 Spiotto MT, Banh A, Papandreou I, Cao H, Galvez MG, Gurtner GC, Denko NC, Le QT, Koong AC. Imaging the unfolded protein response in primary tumors reveals microenvironments with metabolic variations that predict tumor growth. Cancer Research. 70: 78-88. PMID 20028872 DOI: 10.1158/0008-5472.Can-09-2747  0.377
2010 Jayachandran P, Minn AY, Van Dam J, Norton JA, Koong AC, Chang DT. Interfractional uncertainty in the treatment of pancreatic cancer with radiation. International Journal of Radiation Oncology, Biology, Physics. 76: 603-7. PMID 19879062 DOI: 10.1016/J.Ijrobp.2009.06.029  0.344
2010 La TH, Minn AY, Su Z, Fisher GA, Ford JM, Kunz P, Goodman KA, Koong AC, Chang DT. Multimodality treatment with intensity modulated radiation therapy for esophageal cancer Diseases of the Esophagus. 23: 300-308. PMID 19732129 DOI: 10.1111/J.1442-2050.2009.01004.X  0.369
2010 Taniguchi C, Kielar K, Murphy J, Atwood T, Christman-Skieller C, Dieterich S, Xing L, Koong A, Chang D. Significant Duodenal Dose Variation within the Respiratory Cycle during Stereotactic Body Radiotherapy for Pancreatic Cancer International Journal of Radiation Oncology*Biology*Physics. 78: S329. DOI: 10.1016/J.Ijrobp.2010.07.780  0.312
2010 Bazan JG, Hara W, Kunz P, Fisher GA, Ford JM, Welton ML, Koong A, Shelton A, Goodman KA, Chang DT. Intensity Modulated Radiation Therapy vs. Conventional Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal International Journal of Radiation Oncology Biology Physics. 78. DOI: 10.1016/J.Ijrobp.2010.07.714  0.315
2010 Kielar K, Atwood T, Taniguchi C, Christman-Skieller C, Xing L, Koong A, Chang D. Comparison of RapidArc vs. Conventional Intensity Modulated Radiation Therapy for Stereotactic Body Radiation Therapy for Pancreatic Cancer International Journal of Radiation Oncology*Biology*Physics. 78: S785. DOI: 10.1016/J.Ijrobp.2010.07.1818  0.336
2009 Chen Y, Cairns R, Papandreou I, Koong A, Denko NC. Oxygen consumption can regulate the growth of tumors, a new perspective on the Warburg effect. Plos One. 4: e7033. PMID 19753307 DOI: 10.1371/Journal.Pone.0007033  0.327
2009 Kothary N, Dieterich S, Louie JD, Koong AC, Hofmann LV, Sze DY. A primer on image-guided radiation therapy for the interventional radiologist. Journal of Vascular and Interventional Radiology : Jvir. 20: 859-62. PMID 19481470 DOI: 10.1016/J.Jvir.2009.03.037  0.307
2009 Critchley-Thorne RJ, Simons DL, Yan N, Miyahira AK, Dirbas FM, Johnson DL, Swetter SM, Carlson RW, Fisher GA, Koong A, Holmes S, Lee PP. Impaired interferon signaling is a common immune defect in human cancer. Proceedings of the National Academy of Sciences of the United States of America. 106: 9010-5. PMID 19451644 DOI: 10.1073/Pnas.0901329106  0.315
2009 Kong CS, Narasimhan B, Cao H, Kwok S, Erickson JP, Koong A, Pourmand N, Le QT. The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas. International Journal of Radiation Oncology, Biology, Physics. 74: 553-61. PMID 19427557 DOI: 10.1016/J.Ijrobp.2009.02.015  0.307
2009 Chang DT, Chapman C, Shen J, Su Z, Koong AC. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis. American Journal of Clinical Oncology. 32: 405-10. PMID 19415029 DOI: 10.1097/Coc.0B013E3181917158  0.334
2009 Minn AY, Schellenberg D, Maxim P, Suh Y, McKenna S, Cox B, Dieterich S, Xing L, Graves E, Goodman KA, Chang D, Koong AC. Pancreatic tumor motion on a single planning 4D-CT does not correlate with intrafraction tumor motion during treatment. American Journal of Clinical Oncology. 32: 364-8. PMID 19398901 DOI: 10.1097/Coc.0B013E31818Da9E0  0.316
2009 Bennewith KL, Huang X, Ham CM, Graves EE, Erler JT, Kambham N, Feazell J, Yang GP, Koong A, Giaccia AJ. The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth. Cancer Research. 69: 775-84. PMID 19179545 DOI: 10.1158/0008-5472.Can-08-0987  0.563
2009 Chang DT, Schellenberg D, Shen J, Kim J, Goodman KA, Fisher GA, Ford JM, Desser T, Quon A, Koong AC. Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas. Cancer. 115: 665-72. PMID 19117351 DOI: 10.1002/Cncr.24059  0.302
2009 Erler JT, Bennewith KL, Cox TR, Lang G, Bird D, Koong A, Le QT, Giaccia AJ. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell. 15: 35-44. PMID 19111879 DOI: 10.1016/J.Ccr.2008.11.012  0.518
2009 Schellenberg D, Kim J, Columbo L-, Fisher G, Quon A, Desser T, Maxim P, Goodman K, Chang D, Koong A. 62 Single Fraction Stereotactic Body Radiation Therapy (Sbrt) And Sequential Gemcitabine For The Treatment Of Locally Advanced Pancreatic Cancer Radiotherapy and Oncology. 92. DOI: 10.1016/S0167-8140(12)72449-0  0.354
2009 Spiotto M, Bahn A, Cao H, Le Q, Koong A. The Unique Microenvironments of Spontaneous Tumors Differentially Sensitize Them to Radiation International Journal of Radiation Oncology*Biology*Physics. 75: S171. DOI: 10.1016/J.Ijrobp.2009.07.400  0.351
2008 Tillman GF, Pawlicki T, Koong AC, Goodman KA. Preoperative versus postoperative radiotherapy for locally advanced gastroesophageal junction and proximal gastric cancers: a comparison of normal tissue radiation doses. Diseases of the Esophagus. 21: 437-444. PMID 19125798 DOI: 10.1111/J.1442-2050.2007.00794.X  0.317
2008 Choi CY, Chan DA, Paulmurugan R, Sutphin PD, Le QT, Koong AC, Zundel W, Gambhir SS, Giaccia AJ. Molecular imaging of hypoxia-inducible factor 1 alpha and von Hippel-Lindau interaction in mice. Molecular Imaging. 7: 139-46. PMID 19123984  0.759
2008 Fels DR, Ye J, Segan AT, Kridel SJ, Spiotto M, Olson M, Koong AC, Koumenis C. Preferential cytotoxicity of bortezomib toward hypoxic tumor cells via overactivation of endoplasmic reticulum stress pathways. Cancer Research. 68: 9323-30. PMID 19010906 DOI: 10.1158/0008-5472.Can-08-2873  0.398
2008 Schellenberg D, Goodman KA, Lee F, Chang S, Kuo T, Ford JM, Fisher GA, Quon A, Desser TS, Norton J, Greco R, Yang GP, Koong AC. Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. International Journal of Radiation Oncology, Biology, Physics. 72: 678-86. PMID 18395362 DOI: 10.1016/J.Ijrobp.2008.01.051  0.348
2008 Le QT, Koong A, Lieskovsky YY, Narasimhan B, Graves E, Pinto H, Brown JM, Spielman D. In vivo 1H magnetic resonance spectroscopy of lactate in patients with stage IV head and neck squamous cell carcinoma. International Journal of Radiation Oncology, Biology, Physics. 71: 1151-7. PMID 18258377 DOI: 10.1016/J.Ijrobp.2007.11.030  0.31
2008 Cupp JS, Koong AC, Fisher GA, Norton JA, Goodman KA. Tissue Effects after Stereotactic Body Radiotherapy using Cyberknife for Patients with Abdominal Malignancies Clinical Oncology. 20: 69-75. PMID 17900882 DOI: 10.1016/J.Clon.2007.08.009  0.336
2008 Giaccia AJ, Choi CYH, Chan DA, Paulmurugan R, Sutphin PD, Le QT, Koong AC, Zundel W, Gambhir SS. Molecular imaging of hypoxia-inducible factor 1α and von Hippel-Lindau interaction in mice Molecular Imaging. 7: 139-146. DOI: 10.2310/7290.2008.00017  0.756
2008 Yan BM, Schellenberg D, Koong AC, Dam JV. EUS Guided Gold Fiducial Insertion for Image Guided Radiation Therapy of Pancreatic Cancer Gastrointestinal Endoscopy. 67. DOI: 10.1016/J.Gie.2008.03.564  0.333
2007 Koumenis C, Bi M, Ye J, Feldman D, Koong AC. Hypoxia and the Unfolded Protein Response Methods in Enzymology. 435: 275-293. PMID 17998059 DOI: 10.1016/S0076-6879(07)35014-3  0.359
2007 Le QT, Kong C, Lavori PW, O'byrne K, Erler JT, Huang X, Chen Y, Cao H, Tibshirani R, Denko N, Giaccia AJ, Koong AC. Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas. International Journal of Radiation Oncology, Biology, Physics. 69: 167-75. PMID 17707270 DOI: 10.1016/J.Ijrobp.2007.01.071  0.53
2007 Winner M, Koong AC, Rendon BE, Zundel W, Mitchell RA. Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization. Cancer Research. 67: 186-93. PMID 17210698 DOI: 10.1158/0008-5472.Can-06-3292  0.767
2007 Daly ME, Lieskovsky Y, Pawlicki T, Yau J, Pinto H, Kaplan M, Fee WE, Koong A, Goffinet DR, Xing L, Le QT. Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma Head and Neck. 29: 211-220. PMID 17111429 DOI: 10.1002/Hed.20505  0.325
2007 Feldman D, Koong AC. Irestatin, a potent inhibitor of IRE1{alpha} and the unfolded protein response, is a hypoxia-selective cytotoxin and impairs tumor growth Journal of Clinical Oncology. 25: 3514-3514. DOI: 10.1200/Jco.2007.25.18_Suppl.3514  0.339
2007 Chang ST, Goodman KA, Yang GP, Koong AC. Stereotactic body radiotherapy for unresectable pancreatic cancer. Frontiers of Radiation Therapy and Oncology. 40: 386-394. DOI: 10.1159/0000106048  0.328
2007 Schellenberg D, Chang S, Quon A, Graves E, Goodman K, Koong A. Using Pre-radiation PET Parameters to Predict Survival in Adenocarcinoma of the Pancreas Treated With Gemcitabine and Single Fraction Stereotactic Body Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 69: S312. DOI: 10.1016/J.Ijrobp.2007.07.1369  0.315
2006 Le QT, Loo BW, Ho A, Cotrutz C, Koong AC, Wakelee H, Kee ST, Constantinescu D, Whyte RI, Donington J. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 1: 802-9. PMID 17409963 DOI: 10.1016/S1556-0864(15)30409-3  0.337
2006 Petrik D, Lavori PW, Cao H, Zhu Y, Wong P, Christofferson E, Kaplan MJ, Pinto HA, Sutphin P, Koong AC, Giaccia AJ, Le QT. Plasma osteopontin is an independent prognostic marker for head and neck cancers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 5291-7. PMID 17114663 DOI: 10.1200/Jco.2006.06.8627  0.678
2006 Koong AC, Chauhan V, Romero-Ramirez L. Targeting XBP-1 as a novel anti-cancer strategy Cancer Biology and Therapy. 5: 756-759. PMID 16861911 DOI: 10.4161/Cbt.5.7.2973  0.382
2006 Dornhöfer N, Spong S, Bennewith K, Salim A, Klaus S, Kambham N, Wong C, Kaper F, Sutphin P, Nacamuli R, Nacalumi R, Höckel M, Le Q, Longaker M, Yang G, ... Koong A, et al. Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis. Cancer Research. 66: 5816-27. PMID 16740721 DOI: 10.1158/0008-5472.Can-06-0081  0.794
2006 Xing L, Thorndyke B, Schreibmann E, Yang Y, Li TF, Kim GY, Luxton G, Koong A. Overview of image-guided radiation therapy Medical Dosimetry. 31: 91-112. PMID 16690451 DOI: 10.1016/J.Meddos.2005.12.004  0.325
2006 Le QT, Chen E, Salim A, Cao H, Kong CS, Whyte R, Donington J, Cannon W, Wakelee H, Tibshirani R, Mitchell JD, Richardson D, O'Byrne KJ, Koong AC, Giaccia AJ. An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 1507-14. PMID 16533775 DOI: 10.1158/1078-0432.Ccr-05-2049  0.698
2006 Le QT, Cao H, Koong A, Giaccia A. Comment on: Osteopontin as toxic marker [1] Radiotherapy and Oncology. 78: 230. PMID 16442647 DOI: 10.1016/J.Radonc.2005.12.011  0.443
2006 Dornhöfer N, Spong S, Bennewith K, Salim A, Klaus S, Kambham N, Wong C, Kaper F, Sutphin P, Nacamuli R, Höckel M, Le Q, Longaker M, Yang G, Koong A, et al. Erratum: Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis (Cancer Research (June 1, 2006) 66 (5816-5827)) Cancer Research. 66. DOI: 10.1158/0008-5472.Can-66-15-Cor  0.782
2006 Chang ST, Goodman KA, Quon A, Le QT, Fisher GA, Kuo T, Ford JM, Norton J, Yang GP, Koong AC. 2153 : Phase II Study to Assess the Efficacy of Gemcitabine Chemotherapy Followed by Stereotactic Body Radiotherapy (SBRT) in Patients With Locally Advanced Pancreatic Cancer International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.558  0.323
2006 Choi C, Paulmurugan R, Chan D, Sutphin P, Le Q, Koong A, Gambhir S, Giaccia A. 83 International Journal of Radiation Oncology*Biology*Physics. 66: S48-S49. DOI: 10.1016/J.Ijrobp.2006.07.113  0.745
2005 Koong A, Kong C, Zhao S, Richardson D, O'Byrne K, Pinto H, Denko NC, Giaccia AJ, Le QT. Expression and prognostic significance of tissue hypoxia markers in head and neck squamous cell carcinomas (HNSCC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 5559. PMID 27945317 DOI: 10.1200/Jco.2005.23.16_Suppl.5559  0.481
2005 Le QT, Koong AC, Pinto HA, Giaccia AJ, Kong C. Expression of p16 as a prognostic marker in head and neck squamous cell carcinomas (HNSCC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 5520. PMID 27945247 DOI: 10.1200/Jco.2005.23.16_Suppl.5520  0.508
2005 Spong SM, Dornhofer N, Wong C, Lomongsod E, Salim A, Le Q, Koong A, Klaus S, Giaccia A. Inhibition of pancreatic tumor growth and progression by a human monoclonal antibody specific for connective tissue growth factor. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 4150. PMID 27944587 DOI: 10.1200/Jco.2005.23.16_Suppl.4150  0.553
2005 Feldman DE, Chauhan V, Koong AC. The unfolded protein response: a novel component of the hypoxic stress response in tumors. Molecular Cancer Research : McR. 3: 597-605. PMID 16317085 DOI: 10.1158/1541-7786.Mcr-05-0221  0.394
2005 Le QT, Shi G, Cao H, Nelson DW, Wang Y, Chen EY, Zhao S, Kong C, Richardson D, O'Byrne KJ, Giaccia AJ, Koong AC. Galectin-1: a link between tumor hypoxia and tumor immune privilege. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 8932-41. PMID 16219933 DOI: 10.1200/Jco.2005.02.0206  0.702
2005 Koong AC, Christofferson E, Le QT, Goodman KA, Ho A, Kuo T, Ford JM, Fisher GA, Greco R, Norton J, Yang GP. Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. International Journal of Radiation Oncology, Biology, Physics. 63: 320-3. PMID 16168826 DOI: 10.1016/J.Ijrobp.2005.07.002  0.365
2005 Nelson DW, Cao H, Zhu Y, Sunar-Reeder B, Choi CY, Faix JD, Brown JM, Koong AC, Giaccia AJ, Le QT. A noninvasive approach for assessing tumor hypoxia in xenografts: developing a urinary marker for hypoxia. Cancer Research. 65: 6151-8. PMID 16024616 DOI: 10.1158/0008-5472.Can-04-2602  0.56
2005 Zhu Y, Denhardt DT, Cao H, Sutphin PD, Koong AC, Giaccia AJ, Le QT. Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer. Oncogene. 24: 6555-63. PMID 16007184 DOI: 10.1038/Sj.Onc.1208800  0.719
2005 Choi C, Paulmurugan R, Ghambir S, Koong A, Le Q, Giaccia A. Molecular Imaging of HIF-1α and pVHL Interaction In Vivo: The Study of Structure/Function Relationship Guiding HIF-1α and pVHL International Journal of Radiation Oncology*Biology*Physics. 63: S133-S134. DOI: 10.1016/J.Ijrobp.2005.07.227  0.45
2004 Chen Y, Shi G, Xia W, Kong C, Zhao S, Gaw AF, Chen EY, Yang GP, Giaccia AJ, Le QT, Koong AC. Identification of hypoxia-regulated proteins in head and neck cancer by proteomic and tissue array profiling. Cancer Research. 64: 7302-10. PMID 15492250 DOI: 10.1158/0008-5472.Can-04-0899  0.723
2004 Romero-Ramirez L, Cao H, Nelson D, Hammond E, Lee AH, Yoshida H, Mori K, Glimcher LH, Denko NC, Giaccia AJ, Le QT, Koong AC. XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Cancer Research. 64: 5943-7. PMID 15342372 DOI: 10.1158/0008-5472.Can-04-1606  0.726
2004 Soltys SG, Le QT, Shi G, Tibshirani R, Giaccia AJ, Koong AC. The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 4806-12. PMID 15269156 DOI: 10.1158/1078-0432.Ccr-03-0469  0.472
2004 Tibshirani R, Hastie T, Narasimhan B, Soltys S, Shi G, Koong A, Le QT. Sample classification from protein mass spectrometry, by 'peak probability contrasts'. Bioinformatics (Oxford, England). 20: 3034-44. PMID 15226172 DOI: 10.1093/Bioinformatics/Bth357  0.315
2004 Koong AC, Le QT, Ho A, Fong B, Fisher G, Cho C, Ford J, Poen J, Gibbs IC, Mehta VK, Kee S, Trueblood W, Yang G, Bastidas JA. Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. International Journal of Radiation Oncology, Biology, Physics. 58: 1017-21. PMID 15001240 DOI: 10.1016/J.Ijrobp.2003.11.004  0.348
2004 Romero L, Cao H, Hammond E, Giaccia A, Le Q, Koong A. XBP1 is essential for survival under hypoxic conditions and is required for tumor growth International Journal of Radiation Oncology*Biology*Physics. 60: S192-S193. DOI: 10.1016/j.ijrobp.2004.06.130  0.456
2004 Le Q, Shi G, Nelson D, Patel D, Zhao S, Giaccia A, Kong C, Koong A. Identification of galectin-1 as a novel hypoxia-regulated protein via proteomic approaches International Journal of Radiation Oncology*Biology*Physics. 60: S192. DOI: 10.1016/J.Ijrobp.2004.06.129  0.472
2003 Le QT, Tate D, Koong A, Gibbs IC, Chang SD, Adler JR, Pinto HA, Terris DJ, Fee WE, Goffinet DR. Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma. International Journal of Radiation Oncology, Biology, Physics. 56: 1046-54. PMID 12829140 DOI: 10.1016/S0360-3016(03)00117-2  0.309
2003 Le QT, Kovacs MS, Dorie MJ, Koong A, Terris DJ, Pinto HA, Goffinet DR, Nowels K, Bloch D, Brown JM. Comparison of the comet assay and the oxygen microelectrode for measuring tumor oxygenation in head-and-neck cancer patients. International Journal of Radiation Oncology, Biology, Physics. 56: 375-83. PMID 12738312 DOI: 10.1016/S0360-3016(02)04503-0  0.383
2003 Le QT, Sutphin PD, Raychaudhuri S, Yu SC, Terris DJ, Lin HS, Lum B, Pinto HA, Koong AC, Giaccia AJ. Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 59-67. PMID 12538452  0.686
2003 Mehta VK, Cho C, Ford JM, Jambalos C, Poen J, Koong A, Lin A, Bastidas JA, Young H, Dunphy EP, Fisher G. Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer. International Journal of Radiation Oncology, Biology, Physics. 55: 132-7. PMID 12504045 DOI: 10.1016/S0360-3016(02)03863-4  0.343
2003 Soltys S, Shi G, Tibshirani R, Giaccia A, Koong A, Le Q. The use of plasma SELDI-TOF MS proteomic patterns for detection of head and neck squamous cell cancers (HNSCC) International Journal of Radiation Oncology*Biology*Physics. 57: S202. DOI: 10.1016/S0360-3016(03)01006-X  0.48
2002 Choi C, Fontana L, Sutphin P, Hammond E, Denko N, Giaccia A, Koong A, Le Q. Adipophilin: a novel hypoxia regulated gene International Journal of Radiation Oncology*Biology*Physics. 54: 121. DOI: 10.1016/S0360-3016(02)03265-0  0.663
2001 Le Q, Sutphin P, Raychaudhuri S, Terris D, Lin H, Koong A, Chen U, Tibshirani R, Denko N, Giaccia A. Osteopontin - a new serum marker for tumor hypoxia International Journal of Radiation Oncology*Biology*Physics. 51: 80. DOI: 10.1016/S0360-3016(01)01971-X  0.661
2000 Koong AC, Mehta VK, Le QT, Fisher GA, Terris DJ, Brown JM, Bastidas AJ, Vierra M. Pancreatic tumors show high levels of hypoxia. International Journal of Radiation Oncology, Biology, Physics. 48: 919-22. PMID 11072146 DOI: 10.1016/S0360-3016(00)00803-8  0.38
2000 Zundel W, Schindler C, Haas-Kogan D, Koong A, Kaper F, Chen E, Gottschalk AR, Ryan HE, Johnson RS, Jefferson AB, Stokoe D, Giaccia AJ. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes & Development. 14: 391-6. PMID 10691731 DOI: 10.1101/Gad.14.4.391  0.767
1999 Koong A, Denko N, Schindler C, Le Q, Terris D, Ibrahim H, Goffinet D, Giaccia A. 104 candidate genes for the hypoxic tumor phenotype International Journal of Radiation Oncology*Biology*Physics. 45: 201. DOI: 10.1016/S0360-3016(99)90122-0  0.513
1994 Koong AC, Chen EY, Kim CY, Giaccia AJ. Activators of protein kinase C selectively mediate cellular cytotoxicity to hypoxic cells and not aerobic cells. International Journal of Radiation Oncology, Biology, Physics. 29: 259-65. PMID 8195017 DOI: 10.1016/0360-3016(94)90272-0  0.661
1994 Koong AC, Auger EA, Chen EY, Giaccia AJ. The regulation of GRP78 and messenger RNA levels by hypoxia is modulated by protein kinase C activators and inhibitors. Radiation Research. 138: S60-3. PMID 8146329 DOI: 10.2307/3578763  0.668
1994 Koong AC, Chen EY, Lee AS, Brown JM, Giaccia AJ. Increased cytotoxicity of chronic hypoxic cells by molecular inhibition of GRP78 induction. International Journal of Radiation Oncology, Biology, Physics. 28: 661-6. PMID 8113109 DOI: 10.1016/0360-3016(94)90191-0  0.658
1994 Mivechi NF, Koong AC, Giaccia AJ, Hahn GM. Analysis of HSF-1 phosphorylation in A549 cells treated with a variety of stresses. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 10: 371-9. PMID 7930803 DOI: 10.3109/02656739409010281  0.467
1994 Saad AH, Kuo SS, Koong AC, Hahn GM, Giaccia AJ. Modulation of potassium channels by protein tyrosine kinase inhibitors. Journal of Cellular Physiology. 161: 142-8. PMID 7929599 DOI: 10.1002/Jcp.1041610117  0.47
1994 Koong AC, Chen EY, Denko NC, Stambrook P, Giaccia AJ. Defining the pathway which leads to NF-κB activation by low oxygen conditions International Journal of Radiation Oncology*Biology*Physics. 30: 161. DOI: 10.1016/0360-3016(94)90640-8  0.652
1993 Kuo SS, Saad AH, Koong AC, Hahn GM, Giaccia AJ. Potassium-channel activation in response to low doses of gamma-irradiation involves reactive oxygen intermediates in nonexcitatory cells. Proceedings of the National Academy of Sciences of the United States of America. 90: 908-12. PMID 8430104 DOI: 10.1073/Pnas.90.3.908  0.492
1993 Koong AC, Giaccia AJ, Hahn GM, Saad AH. Activation of potassium channels by hypoxia and reoxygenation in the human lung adenocarcinoma cell line A549. Journal of Cellular Physiology. 156: 341-7. PMID 8344990 DOI: 10.1002/Jcp.1041560217  0.461
1992 Giaccia AJ, Auger EA, Koong A, Terris DJ, Minchinton AI, Hahn GM, Brown JM. Activation of the heat shock transcription factor by hypoxia in normal and tumor cell lines in vivo and in vitro. International Journal of Radiation Oncology, Biology, Physics. 23: 891-7. PMID 1618682 DOI: 10.1016/0360-3016(92)90667-7  0.541
1992 Koong A, Auger E, Brown J, Giaccia A. Development of molecular strategies to exploit tumor hypoxia based on hypoxia regulated gene induction International Journal of Radiation Oncology*Biology*Physics. 24: 163. DOI: 10.1016/0360-3016(92)90200-2  0.535
1991 Brown JM, Koong A. Therapeutic Advantage of Hypoxic Cells in Tumors: A Theoretical Study Journal of the National Cancer Institute. 83: 178-185. PMID 1988703 DOI: 10.1093/Jnci/83.3.178  0.398
Show low-probability matches.